Skip to content
🌐 Global🇮🇳 India📍 Asia-Pacific📍 Bihar📍 Delhi-NCR📍 East India📍 Europe📍 Gujarat📍 Karnataka📍 Kerala📍 Madhya Pradesh📍 Maharashtra📍 Middle East📍 North India📍 Northeast India📍 Punjab📍 Rajasthan📍 South India📍 Tamil Nadu📍 Telangana📍 United Kingdom📍 United States📍 Uttar Pradesh📍 West Bengal📍 West India
LIVE
Home / Business
Business

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

TechCrunchSeptember 23, 20261 min read
Share this story
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

📡 Verified Wire Agency Verified Resource & Provenance
Original Resource
The Next Brief
Get the day's most important stories in one email
AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

Advertisement

Related stories

Most read

  1. 1Lack of hygienic menstrual shelters posing health risk to tribal womenPolitics
  2. 2OpenAI wants to consult elite mathematicians about how to not fumble againTechnology
  3. 3South Korea Aims to Cut Middle East Crude Reliance to 50% by 2035Finance
  4. 4Will Trump's AI rebrand as 'super intelligence' catch on?Technology
  5. 5IIT-Bombay student death: Parents allege he faced casteist abuse, demand arrest of faculty memberPolitics